Sign in Sign up for free

Free Stock Screener

Load
Save
Create a watchlist Help
 
–
×
–
×
–
×
–
×
–
×
–
×
–
×
–
day ×
–
day ×
–
% ×
–
% ×
×
–
×
–
×
–
×
–
×
–
×
–
×
–
×
–
% ×
–
% ×
–
% ×
–
×
–
×
–
×
–
×
–
% ×
–
% ×
–
% ×
–
×
–
×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
day ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
×
–
×
–
×
–
% ×
–
×
–
×
–
% ×
–
×
–
×
–
×
–
×
–
×

WUW
Wüstenrot & Württembergische AG
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions EUR) 29 Sep 2022 29 Jun 2022 30 Mar 2022 30 Dec 2021
Current assets
Cash €88.383 €46.792 €65.691 €72.136
Short term investments €650.404 €677.374
Net receivables €2,359.528 €3,076.748 €3,527.613 €350.767
Inventory €155.774 €151.298 €146.412 €192.56
Other current assets €240.175 €410.606 €421.768 €795.343
Total current assets €13,623.078 €11,547.319 €15,405.152 €9,293.229
Long term investments €23,603.183 €25,638.323 €29,417.677 €34,806.358
Property, plant & equipment €531.629 €531.726 €514.667 €511.739
Goodwill
Intangible assets €119.801 €118.928 €115.104 €114.398
Other assets €28,264.656 €29,944.772 €26,903.027 €30,487.202
Deferred long term asset charges €1,106.862 €1,012.906 €701.298 €155.158
Total assets €66,142.347 €67,781.068 €72,355.627 €75,212.926
Current liabilities
Accounts payable €2,958.36 €3,097.076
Short long term debt
Other current liabilities -€410.192 €2,352.709 €11.259 €923.705
Total current liabilities -€410.192 €5,446.416 €11.259 €4,195.981
Long term debt €5,232.554 €5,146.57 €4,921.41 €4,653.076
Other liabilities €57,671.083 €53,200.912 €62,949.645 €61,423.63
Deferred long term liabilities
Minority interest -€8.082 -€1.556 €14.608 €28.727
Total liabilities €62,549.863 €63,853.6 €67,946.391 €70,339.352
Stockholders' equity
Stock option warrants
Common stock €1,486.253 €490.13 €1,485.086 €489.893
Retained earnings €3,542.34 €3,478.335 €3,498.358 €3,441.733
Treasury stock -€1,428.027 -€1,035.563 -€588.816 -€82.474
Capital surplus €996.122 €995.695
Other stockholder equity -€1,428.027 -€1,035.563 -€588.816 -€82.474
Total stockholder equity €3,600.566 €3,929.024 €4,394.628 €4,844.847
Net tangible assets €3,480.765 €3,810.096 €4,279.524 €4,730.449
(in millions EUR) 2021 2020 2019
Current assets
Cash €72.136 €75.12 €35.758
Short term investments €1,019.113
Net receivables €350.767 €338.883 €337.069
Inventory €192.56 €178.204 €152.828
Other current assets €795.343 €839.192 €3,183.947
Total current assets €9,293.229 €7,900.009 €10,813.236
Long term investments €34,806.358 €39,152.12 €36,074.565
Property, plant & equipment €511.739 €488.44 €397.777
Goodwill
Intangible assets €114.398 €104.764 €99.939
Other assets €30,487.202 €28,842.309 €27,765.65
Deferred long term asset charges €155.158 €230.073 €209.649
Total assets €75,212.926 €76,487.642 €75,151.167
Current liabilities
Accounts payable €3,097.076 €2,816.163 €2,716.518
Short long term debt
Other current liabilities €923.705 €1,175.563 €3,210.616
Total current liabilities €4,195.981 €4,088.126 €6,050.213
Long term debt €4,653.076 €3,965.665 €3,821.602
Other liabilities €61,423.63 €63,265.485 €60,367.002
Deferred long term liabilities
Minority interest €28.727 €42.494 €35.103
Total liabilities €70,339.352 €71,402.491 €70,316.085
Stockholders' equity
Stock option warrants
Common stock €489.893 €490.231 €490.029
Retained earnings €3,441.733 €3,158.949 €3,026.543
Treasury stock -€82.474 €397.245 €286.922
Capital surplus €995.695 €996.232 €996.485
Other stockholder equity -€82.474 €397.245 €286.922
Total stockholder equity €4,844.847 €5,042.657 €4,799.979
Net tangible assets €4,730.449 €4,937.893 €4,700.04

Income statement

XSLX
XSLX
(in millions EUR) 29 Sep 2022 29 Jun 2022 30 Mar 2022 30 Dec 2021
Revenue
Total revenue €1,520.691 €885.584 €1,300.356 €2,111.487
Cost of revenue €1,053.967 €596.088 €952.013 €1,631.91
Gross profit €466.724 €289.496 €348.343 €479.577
Operating activities
Research & development
Selling, general & administrative €229.314 €223.552 €266.223 €262.049
Non-recurring
Other operating expenses -€48.716 -€6.886 -€95.704 -€45.793
Total operating expenses €1,253.089 €829.181 €1,140.962 €1,862.905
Operating income €267.602 €56.403 €159.394 €248.582
Income from continuing operations
Net other income -€184.811 -€3.974999 -€87.67 -€114.211
EBIT €267.602 €56.403 €159.394 €248.582
Interest expense -€103.346 -€85.44 -€87.67 -€101.586
Income before tax €82.791 €52.428 €71.724 €134.371
Income tax expense €18.613 €13.065 €15.067 €19.165
Minority interest -€8.082 -€1.556 €14.608 €28.727
Net income from continuing ops €64.178 €39.363 €56.657 €115.206
Non-recurring events
Discontinued operations
Extraordinary items
Effect of accounting change
Other items
Net income
Net income €63.982 €40.46 €56.83 €115.341
Income (for common shares) €63.982 €40.46 €56.83 €115.341
(in millions EUR) 2021 2020 2019
Revenue
Total revenue €7,866.025 €7,064.676 €7,447.022
Cost of revenue €5,967.772 €5,265.015 €5,401.477
Gross profit €1,898.253 €1,799.661 €2,045.545
Operating activities
Research & development
Selling, general & administrative €961.177 €936.578 €995.102
Non-recurring
Other operating expenses -€60.069 -€41.413 -€12.846
Total operating expenses €6,942.184 €6,237.599 €6,469.082
Operating income €923.841 €827.077 €977.94
Income from continuing operations
Net other income -€443.182 -€520.204 -€624.931
EBIT €923.841 €827.077 €977.94
Interest expense -€430.557 -€472 -€615.373
Income before tax €480.659 €306.873 €353.009
Income tax expense €128.506 €96.122 €103.95
Minority interest €28.727 €42.494 €35.103
Net income from continuing ops €352.153 €210.751 €249.059
Non-recurring events
Discontinued operations
Extraordinary items
Effect of accounting change
Other items
Net income
Net income €350.525 €209.907 €248.076
Income (for common shares) €350.525 €209.907 €248.076

Cash flows

XSLX
XSLX
(in millions EUR) 29 Sep 2022 29 Jun 2022 30 Mar 2022 30 Dec 2021
Net income €63.982 €40.46 €56.83 €115.341
Operating activities
Depreciation
Net income adjustments
Change in accounts receivable
Changes in liabilities
Changes in inventory
Changes in other operating activities
Total cash flows from operations
Investing activities
Capital expenditures
Investments
Other cash flows from investing
Total cash flows from investing
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings
Other cash flows from financing
Total cash flows from financing
Effect of exchange rate
Change in cash and equivalents
(in millions EUR) 2021 2020 2019
Net income €350.525 €209.907 €248.076
Operating activities
Depreciation €116.662 €114.049 €118.387
Net income adjustments €127.019 €44.828 €464.221
Change in accounts receivable
Changes in liabilities
Changes in inventory
Changes in other operating activities -€1,420.401 -€450.415 €298.288
Total cash flows from operations -€795.988 €434.954 €1,060.529
Investing activities
Capital expenditures -€116.955 -€159.823 -€135.5
Investments €464.372 -€491.189 -€1,192.981
Other cash flows from investing
Total cash flows from investing €350.93 -€266.632 -€1,317.478
Financing activities
Dividends paid -€60.885 -€60.927 -€60.902
Sale and purchase of stock
Net borrowings €276.978 €58.768 -€28.784
Other cash flows from financing -€18.72 -€18.797 -€20.187
Total cash flows from financing €197.373 -€20.956 -€109.873
Effect of exchange rate €26.489 €0.95 -€16.359
Change in cash and equivalents -€221.196 €148.316 -€383.181

ASLE
AerSale Corporation
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Current assets
Cash $4.285 $2.637 $5.873 $3.154
Short term investments
Net receivables $37.266 $30.057 $31.239 $29.721
Inventory $378.813 $350.845 $329.168 $326.825
Total current assets $295.828 $288.374 $264.774 $286.128
Long term investments
Property, plant & equipment $90.196 $79.956 $81.686 $83.633
Goodwill & intangible assets $41.329 $41.316 $41.846 $42.381
Total noncurrent assets $302.866 $283.32 $289.164 $267.774
Total investments
Total assets $598.694 $571.694 $553.938 $553.902
Current liabilities
Accounts payable $29.388 $26.278 $29.899 $38.954
Deferred revenue $2.286 $2.009 $2.998 $2.393
Short long term debt $4.33 $5.434 $5.871 $5.21
Total current liabilities $43.008 $40.246 $45.713 $56.92
Long term debt $104.792 $78.894 $60.658 $41.765
Total noncurrent liabilities $105.887 $79.465 $63.21 $45.72
Total debt $109.122 $84.328 $66.529 $46.975
Total liabilities $148.895 $119.711 $108.923 $102.64
Stockholders' equity
Retained earnings $135.911 $139.548 $133.271 $136.003
Other stockholder equity
Total stockholder equity $449.799 $451.983 $445.015 $451.262
(in millions USD) 2023 2022 2021
Current assets
Cash $5.873 $147.188 $130.188
Short term investments
Net receivables $31.239 $28.273 $42.571
Inventory $329.168 $183.53 $159.293
Total current assets $264.774 $333.556 $271.529
Long term investments
Property, plant & equipment $81.686 $75.55 $80.714
Goodwill & intangible assets $41.846 $43.972 $46.098
Total noncurrent assets $289.164 $198.023 $215.956
Total investments
Total assets $553.938 $531.579 $487.485
Current liabilities
Accounts payable $29.899 $21.131 $19.967
Deferred revenue $2.998 $1.355 $2.86
Short long term debt $5.871 $4.426
Total current liabilities $45.713 $52.84 $67.906
Long term debt $60.658 $28.283
Total noncurrent liabilities $63.21 $33.759 $10.7
Total debt $66.529 $32.709
Total liabilities $108.923 $86.599 $78.606
Stockholders' equity
Retained earnings $133.271 $138.834 $94.973
Other stockholder equity
Total stockholder equity $445.015 $444.98 $408.879

Income statement

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Revenue
Total revenue $77.101 $90.54 $94.422 $92.484
Cost of revenue $55.381 $61.744 $70.006 $69.01
Gross profit $21.72 $28.796 $24.416 $23.474
Operating activities
Research & development
Selling, general & administrative $23.572 $24.133 $25.467 $25.403
Total operating expenses $23.572 $24.133 $25.467 $25.403
Operating income -$1.852 $4.663 -$1.051 -$1.929
Income from continuing operations
EBIT -$1.612 $6.811 $0.383 -$1.857
Income tax expense $0.497 -$0.401 $2.092 -$1.959
Interest expense $1.528 $0.935 $1.023 $0.25
Net income
Net income -$3.637 $6.277 -$2.732 -$0.148
Income (for common shares) -$3.637 $6.277 -$2.732 -$0.148
(in millions USD) 2023 2022 2021
Revenue
Total revenue $334.503 $408.544 $340.437
Cost of revenue $242.082 $257.15 $221.045
Gross profit $92.421 $151.394 $119.392
Operating activities
Research & development
Selling, general & administrative $103.191 $96.348 $77.498
Total operating expenses $103.191 $96.348 $62.73
Operating income -$10.77 $55.046 $56.662
Income from continuing operations
EBIT -$7.834 $56.789 $48.754
Income tax expense -$2.116 $14.021 $11.659
Interest expense -$0.155 -$1.093 $0.98
Net income
Net income -$5.563 $43.861 $36.115
Income (for common shares) -$5.563 $43.861 $36.115

Cash flows

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Net income -$3.637 $6.277 -$2.732 -$0.148
Operating activities
Depreciation $3.694 $2.819 $2.947 $2.604
Business acquisitions & disposals
Stock-based compensation $1.144 $0.799 $3.112 $3.18
Total cash flows from operations -$15.327 -$21.473 -$6.099 -$38.854
Investing activities
Capital expenditures -$9.226 $0.226 -$3.593 -$1.202
Investments
Total cash flows from investing -$9.226 $0.226 -$3.593 -$1.202
Financing activities
Dividends paid
Sale and purchase of stock $0.325 $0.288
Net borrowings $25.892 $18.119 $19.038 $8.6
Total cash flows from financing $26.201 $18.011 $12.411 $8.566
Effect of exchange rate
Change in cash and equivalents $1.648 -$3.236 $2.719 -$31.49
(in millions USD) 2023 2022 2021
Net income -$5.563 $43.861 $36.115
Operating activities
Depreciation $10.818 $11.857 $12.998
Business acquisitions & disposals
Stock-based compensation $12.051 $16.498 $12.721
Total cash flows from operations -$174.15 -$0.113 $79.079
Investing activities
Capital expenditures $3.091 $37.176 $13.204
Investments
Total cash flows from investing $3.091 $41.371 $13.204
Financing activities
Dividends paid
Sale and purchase of stock $0.566 -$21.666 $9.282
Net borrowings $36.197
Total cash flows from financing $29.744 -$24.258 $8.588
Effect of exchange rate
Change in cash and equivalents -$141.315 $17 $100.871

CTHR
Charles & Colvard Ltd
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 31 Mar 2024 31 Dec 2023 30 Sep 2023 30 Jun 2023
Current assets
Cash $9.239602 $11.087187 $12.67202 $15.568911
Short term investments $0.25 $0.25 $0.25 $0.25
Net receivables $0.56657 $1.528476 $0.442693 $0.380085
Inventory $25.307687 $25.762435 $27.329725 $26.753576
Total current assets $21.290144 $23.682986 $22.597196 $24.576396
Long term investments
Property, plant & equipment $4.414608 $4.511815 $4.563449 $4.674801
Goodwill & intangible assets $0.340528 $0.338222 $0.315776 $0.305703
Total noncurrent assets $19.672729 $20.782574 $23.995565 $24.307692
Total investments $0.25 $0.25 $0.25 $0.25
Total assets $40.962873 $44.46556 $46.592761 $48.884088
Current liabilities
Accounts payable $5.865435 $6.049022 $5.652218 $4.786155
Deferred revenue
Short long term debt $1.398217 $0.892147 $0.886117 $0.880126
Total current liabilities $8.619916 $8.345994 $7.46372 $7.06176
Long term debt $1.417478 $1.631724 $1.842468 $2.047742
Total noncurrent liabilities $1.417478 $1.631724 $1.842468 $2.047742
Total debt $2.815695 $2.523871 $2.728585 $2.927868
Total liabilities $10.037394 $9.977718 $9.306188 $9.109502
Stockholders' equity
Retained earnings -$52.221634 -$48.588927 -$45.723022 -$43.183565
Other stockholder equity
Total stockholder equity $30.925479 $34.487842 $37.286573 $39.774586
(in millions USD) 2023 2022 2021
Current assets
Cash $15.568911 $21.17934 $21.446951
Short term investments $0.25 $0.25 $0.25
Net receivables $0.380085 $2.220816 $1.662074
Inventory $26.753576 $33.5128 $29.17272
Total current assets $24.576396 $35.864444 $35.761231
Long term investments
Property, plant & equipment $4.674801 $4.688595 $4.828043
Goodwill & intangible assets $0.305703 $0.26573 $0.209658
Total noncurrent assets $24.307692 $33.344411 $29.160768
Total investments $0.25 $0.25 $0.25
Total assets $48.884088 $69.208855 $64.921999
Current liabilities
Accounts payable $4.786155 $4.401229 $2.774373
Deferred revenue
Short long term debt $0.880126 $0.856571 $0.566083
Total current liabilities $7.06176 $6.804283 $5.622263
Long term debt $2.047742 $2.846805 $3.600842
Total noncurrent liabilities $2.047742 $2.846805 $3.61072
Total debt $2.927868 $3.703376 $4.166925
Total liabilities $9.109502 $9.651088 $9.232983
Stockholders' equity
Retained earnings -$43.183565 -$23.602771 -$25.976686
Other stockholder equity
Total stockholder equity $39.774586 $59.557767 $55.689016

Income statement

XSLX
XSLX
(in millions USD) 31 Mar 2024 31 Dec 2023 30 Sep 2023 30 Jun 2023
Revenue
Total revenue $5.261966 $7.905639 $4.953023 $5.564231
Cost of revenue $4.076081 $5.049947 $3.008507 $10.561473
Gross profit $1.185885 $2.855692 $1.944516 -$4.997242
Operating activities
Research & development
Selling, general & administrative $4.884017 $5.793385 $4.576233 $4.340017
Total operating expenses $4.884017 $5.793385 $4.576233 $4.340017
Operating income -$3.698132 -$2.937693 -$2.631717 -$9.337259
Income from continuing operations
EBIT -$3.623604 -$2.860334 -$2.539457 -$9.208932
Income tax expense $0.043881
Interest expense $0.009103 $0.005571
Net income
Net income -$3.632707 -$2.865905 -$2.539457 -$9.252813
Income (for common shares) -$3.632707 -$2.865905 -$2.539457 -$9.252813
(in millions USD) 2023 2022 2021
Revenue
Total revenue $29.946234 $43.089024 $39.235839
Cost of revenue $25.212383 $22.845702 $20.80969
Gross profit $4.733851 $20.243322 $18.426149
Operating activities
Research & development
Selling, general & administrative $18.709871 $17.370118 $12.918157
Total operating expenses $18.709871 $17.370118 $12.918157
Operating income -$13.97602 $2.873204 $5.507992
Income from continuing operations
EBIT -$13.678758 $2.892447 $6.487298
Income tax expense $5.902036 $0.518532 -$6.332421
Interest expense $0.008953
Net income
Net income -$19.580794 $2.373915 $12.810766
Income (for common shares) -$19.580794 $2.373915 $12.810766

Cash flows

XSLX
XSLX
(in millions USD) 31 Mar 2024 31 Dec 2023 30 Sep 2023 30 Jun 2023
Net income -$3.632707 -$2.865905 -$2.539457 -$9.252813
Operating activities
Depreciation $0.173142 $0.178728 $0.178291 $0.175872
Business acquisitions & disposals
Stock-based compensation $0.070343 $0.067174 $0.051444 $0.040109
Total cash flows from operations -$2.111987 -$1.279389 -$2.665383 -$0.047621
Investing activities
Capital expenditures -$0.227954 -$0.27825 -$0.217052 -$0.345541
Investments
Total cash flows from investing -$0.235598 -$0.305444 -$0.231508 -$0.354096
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings $0.5
Total cash flows from financing $0.5
Effect of exchange rate
Change in cash and equivalents -$1.847585 -$1.584833 -$2.896891 -$0.401717
(in millions USD) 2023 2022 2021
Net income -$19.580794 $2.373915 $12.810766
Operating activities
Depreciation $0.653157 $0.479308 $0.567122
Business acquisitions & disposals
Stock-based compensation $0.249428 $0.774341 $0.352583
Total cash flows from operations -$3.875091 $0.572553 $6.473092
Investing activities
Capital expenditures -$1.229571 -$1.496471 -$0.437069
Investments -$0.25
Total cash flows from investing -$1.283523 -$1.560659 -$0.733465
Financing activities
Dividends paid
Sale and purchase of stock -$0.451815 -$0.038164
Net borrowings
Total cash flows from financing -$0.451815 $0.720495 $1.09009
Effect of exchange rate
Change in cash and equivalents -$5.610429 -$0.267611 $6.829717

SCNA
Smart Cannabis Corp.
Compare

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 29 Jun 2017 30 Mar 2017 30 Dec 2016 29 Sep 2016
Current assets
Cash $0.241507 $0.066378 $0.009845 -$0.042043
Short term investments
Net receivables $1.314509 $0.290465 $0.35 $0.014741
Inventory
Other current assets $0.001226 $0.032903
Total current assets $1.556016 $0.356844 $0.361071 $0.005601
Long term investments $0.209398
Property, plant & equipment $0.001112
Goodwill
Intangible assets $0.231788
Other assets $0.855
Deferred long term asset charges
Total assets $1.556016 $1.211844 $0.361071 $0.447899
Current liabilities
Accounts payable $0.163336 $0.020849 $0.041848
Short long term debt $0.0095 $0.0095 $0.312995
Other current liabilities $0.02685 $0.466056
Total current liabilities $0.172836 $0.057199 $0.354843 $0.070153
Long term debt $0.348292 $0.302995 $0.070153
Other liabilities $0.57
Deferred long term liabilities
Minority interest
Total liabilities $0.521128 $0.930194 $0.354843 $0.466056
Stockholders' equity
Stock option warrants
Common stock $0.060246 $0.00051
Retained earnings $1.383181 $0.28165 $0.005718 -$0.052506
Treasury stock
Capital surplus
Other stockholder equity -$0.408538 $0.00051
Total stockholder equity $1.034889 $0.28165 $0.006228 -$0.051996
Net tangible assets $1.034889 $0.28165 $0.006228 -$0.283784
(in millions USD) 2017 2016 2015
Current assets
Cash $0.450535 $0.009845 -$0.012029
Short term investments
Net receivables $0.540708 $0.35 $0.012341
Inventory $0.203903 $0.162085
Other current assets $0.001226 $0.015387
Total current assets $1.195146 $0.361071 $0.177784
Long term investments $0.12
Property, plant & equipment $0.10561 $0.000455
Goodwill
Intangible assets $0.38014
Other assets
Deferred long term asset charges
Total assets $1.300756 $0.361071 $0.678379
Current liabilities
Accounts payable $0.04 $0.041848 $0.011354
Short long term debt $0.393292 $0.312995
Other current liabilities $0.283903 $0.012984
Total current liabilities $0.717195 $0.354843 $0.524478
Long term debt $0.211957
Other liabilities -$0.00045
Deferred long term liabilities
Minority interest
Total liabilities $0.717195 $0.354843 $0.735985
Stockholders' equity
Stock option warrants
Common stock $0.058967 $0.00051 $0.00045
Retained earnings -$1.522274 $0.005718 -$0.058056
Treasury stock
Capital surplus $2.046864
Other stockholder equity
Total stockholder equity $0.583561 $0.006228 -$0.057606
Net tangible assets $0.583561 $0.006228 -$0.437746

Income statement

XSLX
XSLX
(in millions USD) 29 Jun 2017 30 Mar 2017 30 Dec 2016 29 Sep 2016
Revenue
Total revenue $2.041557 $0.544467 $0.194006 $0.004653
Cost of revenue $0.883707 $0.237706 $0.157712 $0.001847
Gross profit $1.15785 $0.306761 $0.0326 $0.0065
Operating activities
Research & development
Selling, general & administrative $0.095666 $0.025111 $0.025111 $0.007902
Non-recurring
Other operating expenses
Total operating expenses
Operating income $1.056686 $0.28165 $0.041894 -$0.001403
Income from continuing operations
Net other income
EBIT $1.056686 $0.28165 $0.039793 -$0.001402
Interest expense $0.005499 $0.005499 $0.005499 $0.005499
Income before tax $1.051187 $0.28165 $0.039793 -$0.001402
Income tax expense
Minority interest
Net income from continuing ops $1.051187 $0.28165 $0.039793 -$0.001402
Non-recurring events
Discontinued operations
Extraordinary items
Effect of accounting change
Other items
Net income
Net income $1.056686 $0.28165 $0.040125 -$0.001734
Income (for common shares) $1.056686 $0.28165 $0.040125 -$0.001734
(in millions USD) 2017 2016 2015
Revenue
Total revenue $3.137886 $0.225059 $0.083568
Cost of revenue $1.716221 $0.153559 $0.040791
Gross profit $1.421665 $0.0715 $0.042777
Operating activities
Research & development
Selling, general & administrative $2.849426 $0.007726 $0.074332
Non-recurring $0.1 $0.1
Other operating expenses $0.000231 $0.000231
Total operating expenses $0.115123
Operating income -$1.527992 $0.063774 -$0.031555
Income from continuing operations
Net other income $0.000053
EBIT -$1.527992 $0.063774 -$0.031555
Interest expense
Income before tax -$1.527992 $0.063774 -$0.031501
Income tax expense
Minority interest
Net income from continuing ops -$1.527992 $0.063774 -$0.031501
Non-recurring events
Discontinued operations
Extraordinary items
Effect of accounting change
Other items
Net income
Net income -$1.527992 $0.063774 -$0.031501
Income (for common shares) -$1.527992 $0.063774 -$0.031501

Cash flows

XSLX
XSLX
(in millions USD) 29 Jun 2017 30 Mar 2017 30 Dec 2016 29 Sep 2016
Net income $1.056686 $0.28165 $0.040125 -$0.001734
Operating activities
Depreciation
Net income adjustments
Change in accounts receivable -$1.024044 -$1.024044 -$1.024044 -$1.024044
Changes in liabilities $0.142487 $0.142487 $0.142487 $0.142487
Changes in inventory
Changes in other operating activities
Total cash flows from operations $0.175129 $0.057034 $0.031601 $0.001654
Investing activities
Capital expenditures
Investments
Other cash flows from investing
Total cash flows from investing
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings
Other cash flows from financing
Total cash flows from financing
Effect of exchange rate
Change in cash and equivalents $0.175129 $0.057034 $0.081876 -$0.00008
(in millions USD) 2017 2016 2015
Net income -$1.527992 $0.063774 -$0.031501
Operating activities
Depreciation $0.000231 $0.000231
Net income adjustments $2.515 -$0.062341 $0.018733
Change in accounts receivable -$0.595708 -$0.595708
Changes in liabilities $0.323903 $0.323903
Changes in inventory -$0.203903 -$0.203903
Changes in other operating activities
Total cash flows from operations $0.511531 $0.001433 -$0.012768
Investing activities
Capital expenditures -$0.105841 -$0.105841
Investments
Other cash flows from investing -$0.003492
Total cash flows from investing -$0.105841 -$0.105841 -$0.003492
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings $0.035 $0.035
Other cash flows from financing -$0.003931
Total cash flows from financing $0.035 $0.02 -$0.003931
Effect of exchange rate
Change in cash and equivalents $0.44069 $0.021433 -$0.026157

HTSF
Heartsoft, Inc.
Compare

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 30 Dec 2001 29 Sep 2001 29 Jun 2001 30 Mar 2001
Current assets
Cash -$0.032394 $0.013135
Short term investments
Net receivables $0.255576 $0.256058 $0.271716 $0.33536
Inventory $0.04988 $0.051377 $0.05726 $0.06166
Other current assets $0.029746 $0.048277 $0.159334
Total current assets $0.301062 $0.337181 $0.377253 $0.569489
Long term investments
Property, plant & equipment $0.134417 $0.128574 $0.137574 $0.151505
Goodwill
Intangible assets $0.955385 $0.93038 $0.934823 $0.964504
Other assets $0.001319 $0.004668 $0.004668 $0.004668
Deferred long term asset charges
Total assets $1.392183 $1.400803 $1.454318 $1.690166
Current liabilities
Accounts payable $0.80441 $0.798553 $0.493779 $0.452667
Short long term debt $1.232013 $0.965059
Other current liabilities $0.03148
Total current liabilities $2.392389 $2.44922 $2.060227 $1.654834
Long term debt $0.028539 $0.025245
Other liabilities $0.156975
Deferred long term liabilities
Minority interest
Total liabilities $2.549364 $2.44922 $2.088766 $1.680079
Stockholders' equity
Stock option warrants
Common stock $0.008999 $0.008999 $0.008084 $0.007352
Retained earnings -$9.130327 -$9.001563 -$8.366594 -$7.499939
Treasury stock
Capital surplus $7.957727 $7.937727 $7.717642 $7.494504
Other stockholder equity
Total stockholder equity -$1.163601 -$1.054837 -$0.640868 $0.001917
Net tangible assets -$2.118986 -$1.985217 -$1.575691 -$0.962587
(in millions USD) 2001 2000 2000
Current assets
Cash $0.09382 $0.334794
Short term investments
Net receivables $0.271716 $0.064412 $0.030655
Inventory $0.05726 $0.04702 $0.045694
Other current assets $0.048277 $0.007059 $0.009219
Total current assets $0.377253 $0.212311 $0.420362
Long term investments
Property, plant & equipment $0.137574 $0.106129 $0.103246
Goodwill
Intangible assets $0.934823 $0.745378 $0.693419
Other assets $0.004668 $0.004668 $0.004608
Deferred long term asset charges
Total assets $1.454318 $1.068486 $1.221635
Current liabilities
Accounts payable $0.493779 $0.283639 $0.218753
Short long term debt $1.232013
Other current liabilities
Total current liabilities $2.060227 $0.597956 $0.50385
Long term debt $0.028539
Other liabilities
Deferred long term liabilities
Minority interest
Total liabilities $2.088766 $0.597956 $0.50385
Stockholders' equity
Stock option warrants
Common stock $0.008084 $0.005653 $0.005528
Retained earnings -$8.366594 -$5.396714 -$4.901959
Treasury stock
Capital surplus $7.717642 $5.853321 $5.605946
Other stockholder equity
Total stockholder equity -$0.640868 $0.46226 $0.709515
Net tangible assets -$1.575691 -$0.283118 $0.016096

Income statement

XSLX
XSLX
(in millions USD) 30 Dec 2001 29 Sep 2001 29 Jun 2001 30 Mar 2001
Revenue
Total revenue $0.081556 $0.062646 $0.147222 $0.158441
Cost of revenue -$0.061084 $0.07531 $0.157067 $0.151338
Gross profit $0.14264 -$0.012664 -$0.009845 $0.007103
Operating activities
Research & development
Selling, general & administrative $0.264165 $0.436128 $0.627649 $0.582658
Non-recurring
Other operating expenses
Total operating expenses $0.203081 $0.578247 $0.857305 $0.786029
Operating income -$0.121525 -$0.515601 -$0.710083 -$0.627588
Income from continuing operations
Net other income -$0.007164 -$0.138275 -$0.156572 -$0.118123
EBIT -$0.121525 -$0.515601 -$0.710083 -$0.627588
Interest expense -$0.000764 -$0.144675 -$0.159856 -$0.125851
Income before tax -$0.128689 -$0.653876 -$0.866655 -$0.745711
Income tax expense
Minority interest
Net income from continuing ops -$0.128689 -$0.653876 -$0.866655 -$0.745711
Non-recurring events
Discontinued operations
Extraordinary items
Effect of accounting change
Other items
Net income
Net income -$0.128689 -$0.653876 -$0.866655 -$0.745711
Income (for common shares) -$0.128689 -$0.653876 -$0.866655 -$0.745711
(in millions USD) 2001 2000 2000
Revenue
Total revenue $0.513996 $0.34296 $0.315557
Cost of revenue $0.41025 $0.204323 $0.158988
Gross profit $0.103746 $0.138637 $0.156569
Operating activities
Research & development
Selling, general & administrative $2.519848 $1.812542 $1.48412
Non-recurring
Other operating expenses
Total operating expenses $3.128372 $2.176753 $1.791945
Operating income -$2.614376 -$1.833793 -$1.476388
Income from continuing operations
Net other income -$0.355504 -$0.137179 -$0.14406
EBIT -$2.614376 -$1.833793 -$1.476388
Interest expense -$0.370237 -$0.134072 -$0.143089
Income before tax -$2.96988 -$1.970972 -$1.620448
Income tax expense
Minority interest
Net income from continuing ops -$2.96988 -$1.970972 -$1.620448
Non-recurring events
Discontinued operations
Extraordinary items
Effect of accounting change
Other items
Net income
Net income -$2.96988 -$1.970972 -$1.620448
Income (for common shares) -$2.96988 -$1.970972 -$1.620448

Cash flows

XSLX
XSLX
(in millions USD) 30 Dec 2001 29 Sep 2001 29 Jun 2001 30 Mar 2001
Net income -$0.128689 -$0.653876 -$0.866655 -$0.745711
Operating activities
Depreciation $0.013443 -$0.091941 $0.052033
Net income adjustments -$0.000002 $0.192249 $0.725181
Change in accounts receivable $0.004731 $0.074373 -$0.051027
Changes in liabilities $0.415765 $0.041113 $0.12582
Changes in inventory $0.005885 $0.0044 -$0.008178
Changes in other operating activities $0.06072 -$0.0526 -$0.483513
Total cash flows from operations -$0.153334 -$0.534531 -$0.433976
Investing activities
Capital expenditures -$0.000851 -$0.00929
Investments
Other cash flows from investing $0.250254 $0.250254
Total cash flows from investing $0.221277 -$0.052084
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings $0.059017 $0.270247 $0.326073
Other cash flows from financing
Total cash flows from financing $0.153334 $0.300119 $0.481264
Effect of exchange rate
Change in cash and equivalents -$0.013135 -$0.004796
(in millions USD) 2001 2000 2000
Net income -$2.96988 -$1.970972 -$1.620448
Operating activities
Depreciation $0.033744 $0.110371 $0.148836
Net income adjustments $0.973339 $0.148221 $0.148268
Change in accounts receivable $0.053679 $0.028323 $0.015943
Changes in liabilities $0.21014 $0.112941 $0.025013
Changes in inventory -$0.01024 -$0.013784 -$0.025343
Changes in other operating activities -$0.215532 $0.150039 $0.062847
Total cash flows from operations -$1.76022 -$1.446519 -$1.244884
Investing activities
Capital expenditures -$0.065189 -$0.079305 -$0.075554
Investments
Other cash flows from investing
Total cash flows from investing -$0.419164 -$0.31753 -$0.274837
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings $1.194001 -$0.422421 -$0.270595
Other cash flows from financing
Total cash flows from financing $2.085564 $1.85052 $1.812926
Effect of exchange rate
Change in cash and equivalents -$0.09382 $0.086471 $0.293205